Usted buscó: spinosad (Inglés - Croata)

spinosad / milbemycin oxime
spinosad / milbemicin oksim

comfortis 1040 mg 1040 mg spinosad
comfortis 1040 mg 1040 mg spinosada

number of tablets and strength (mg spinosad)
broj tableta i jačina tableta (mg spinosada)

comfortis is a veterinary medicine that contains spinosad.
comfortis je veterinarsko-medicinski proizvod koji sadrži spinosad.

spinosad is excreted in the colostrum and milk of lactating bitches.
spinosad se izlučuje kroz kolostrum i mlijeko kuja koje doje.

in lactating bitches, spinosad is excreted in the colostrum/milk.
kod kuja dojilja, spinosad se izlučuje kolostrumom/mlijekom.

the safety of spinosad in pregnant cats (queens) has not been evaluated.
neškodljivost spinosada kod gravidnih mačaka nije procijenjena.

comfortis 1620 mg spinosad 1620 mg for the full list of excipients, see section 6.1.
comfortis 1620 mg spinosad 1620 mg potpuni popis pomoćnih tvari vidi u odjeljku 6.1.

milbemycin oxime plasma concentrations and some pharmacokinetic parameters are increased in the presence of spinosad.
koncentracije milbemicin oksima u plazmi i neki farmakokinetički parametri povećani su u prisutnosti spinosada.

in pregnant dogs (bitches), the safety of spinosad has not been sufficiently established.
kod gravidnih pasa (kuja), neškodljivost spinosada nije dovoljno ustanovljena.

189 dogs were treated with simparica for three months whilst 96 dogs were given another medicine, spinosad.
189 pasa liječeno je vmp-om simparica tijekom tri mjeseca dok je 96 pasa primilo drugi vmp, spinosad.

at doses of approximately 2.5 times the recommended dose, spinosad caused vomiting in the vast majority of dogs.
u dozama od otprilike 2,5 puta većim od preporučene, spinosad uzrokuje povraćanje kod velike većine pasa.

therefore, it is recommended to treat cats with food as this maximises the opportunity for fleas to ingest lethal amounts of spinosad.
prema tome, preporučuje se tretiranje mačaka uz davanje hrane radi maksimiziranja mogućnosti da buhe progutaju smrtonosne količine spinosada.

monthly repeated oral administration of spinosad and milbemycin oxime over six months revealed evidence of spinosad and milbemycin oxime accumulation in juvenile dogs.
ponovljena mjesečna peroralna primjena spinosada i milbemicin oksima tijekom šest mjeseci otkrila je nakupljanje spinosada i milbemicin oksima kod mladih pasa.

after spinosad administration, the incidence of vomiting on the day of, or the day after dosing has been observed to increase as a function of the dose.
nakon primjene spinosada primijećen je porast učestalosti povraćanja na dan primjene ili dan nakon nje, ovisno o dozi.

the oral administration of spinosad and milbemycin oxime combination tablets at mean cumulative monthly doses up to 255mg spinosad and 4.2 mg milbemycin oxime per kg body weight (up to
peroralnu primjenu kombinacije spinosada i milbemicin oksima u tabletama u srednjim kumulativnim mjesečnim dozama do 255 mg spinosada i 4,2 mg milbemicin oksima po kg tjelesne težine (do

after oral administration of 45 mg spinosad and 0.75 mg milbemycin oxime/kg bodyweight to fed dogs, spinosyns a and d are rapidly absorbed and extensively distributed.
nakon peroralne primjene 45 mg spinosada i 0,75 mg milbemicin oksima po kg tjelesne težine kod sitih pasa, spinosini a i d brzo se apsorbiraju i široko raspodjeljuju.

in addition, in studies containing only spinosad, auc and cmax values were higher in fed than fasted dogs and therefore it is recommended to treat dogs with food as this maximises the opportunity for fleas to ingest lethal amounts of spinosad.
dodatno, u ispitivanjima koja su sadržavala samo spinosad, pik i cmax vrijednosti su bile veće kod sitih nego kod gladnih pasa te se prema tome preporučuje liječenje pasa uz davanje hrane jer takav način povećava mogućnosti da buhe progutaju smrtonosnu dozu spinosada.

comfortis tablets must not be used in dogs or cats aged less than 14 weeks, or in dogs or cats that are hypersensitive (allergic) to spinosad or any of the other ingredients in the tablets.
tablete comfortis ne smiju se koristiti u pasa i mačaka mlađih od 14 tjedana, ili u pasa i mačaka koji su preosjetljivi (alergični) na spinosad ili bilo koju drugu pomoćnu tvar u tabletama.

regular monthly treatments with the insecticidal active substance in this product (spinosad) break the fleas’ life cycle and may be used to control the flea population in contaminated households.
redovno mjesečno liječenje insekticidnom djelatnom tvari spinosad, prekida životni ciklus buha i može se upotrijebiti u kontroli populacije buha u kontaminiranim kućanstvima.